Seres Therapeutics Inc. (MCRB)
NASDAQ: MCRB
· Real-Time Price · USD
16.70
-0.16 (-0.95%)
At close: Aug 15, 2025, 3:59 PM
16.08
-3.74%
After-hours: Aug 15, 2025, 07:58 PM EDT
Seres Therapeutics Cash Flow Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | -19.86M | 32.68M | -15.64M | 88.78M | -32.87M | -40.13M | -41.25M | -47.85M | 46.55M | -71.17M | -68.8M | -60M | -64.73M | -56.62M | -50M | 68.22M | -48.33M | -35.47M |
Depreciation & Amortization | 1.06M | 1.08M | 1.08M | 1.4M | 1.42M | 1.56M | 4.05M | 1.68M | 1.53M | 1.4M | 1.63M | 1.75M | 1.69M | 1.57M | 1.55M | 1.49M | 1.43M | 1.48M |
Stock-Based Compensation | 2.34M | 2.82M | 3.77M | 5.18M | 5.53M | 6.49M | 5.09M | 8.67M | 13.49M | 6.85M | 7.29M | 6.36M | 6.75M | 5.08M | 5.67M | 5.85M | 5.08M | 3.62M |
Other Working Capital | n/a | -9.05M | -23.9M | 26.27M | 5.98M | 323K | -7.41M | 10.7M | 1.34M | -15.53M | -955K | -3.44M | -1.22M | -10.53M | -7.22M | 12.77M | -5.26M | -4.65M |
Other Non-Cash Items | 3.17M | n/a | 2.03M | -155.83M | 2.74M | 25.09M | 21.17M | -20.34M | 4.43M | 5.68M | 2.49M | 2.53M | 1.71M | 528K | 508K | -173K | 933K | 773K |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | n/a | -21.17M | 21.37M | 1.44M | n/a | n/a | n/a | n/a | n/a | 429K | 516K | 730K | 851K |
Change in Working Capital | n/a | -11.71M | -30.13M | 25.79M | -16.64M | -9.15M | -15.39M | -22.79M | -1.46M | -19.34M | 4.5M | -10.35M | 4.46M | -17M | -10.03M | 51.84M | 468K | -755K |
Operating Cash Flow | -13.29M | 26.91M | -38.88M | -34.68M | -39.81M | -35.24M | -47.5M | -59.26M | 65.98M | -76.58M | -52.89M | -59.58M | -49.9M | -66.44M | -51.86M | 127.74M | -39.7M | -29.5M |
Capital Expenditures | -181K | -34K | -90K | -129K | -99K | -62K | -877K | -1.8M | -1.23M | -4.07M | -3.46M | -1.25M | -2.16M | -2.95M | -1.58M | -4.09M | -2.55M | -1.34M |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | 6.81M | n/a | n/a | -6.81M | -9.39M | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | n/a | n/a | n/a | 13.52M | n/a | n/a | n/a | n/a | n/a | -4.43M | -12.08M | n/a | -7.98M | -28.16M | -29.63M | -14.4M | -5M | -46.94M |
Sales Maturities Of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 11.75M | 11.23M | 21.47M | 41.38M | 33.54M | 44.08M | 43.64M | 43.6M | 54.83M | 27.55M |
Other Investing Acitivies | n/a | n/a | n/a | 127.76M | 1.4M | n/a | -6.81M | n/a | 11.75M | 6.81M | 9.39M | 41.38M | 25.56M | 15.92M | 750K | 29.2M | -750K | -19.4M |
Investing Cash Flow | -181K | -34K | -90K | 141.14M | 1.3M | -62K | -877K | -1.8M | 10.52M | 2.74M | 5.93M | 40.13M | 23.4M | 12.97M | 13.19M | 25.11M | 46.53M | -20.74M |
Debt Repayment | n/a | n/a | n/a | -127.91M | n/a | n/a | n/a | n/a | 50.52M | n/a | n/a | n/a | n/a | 25.7M | n/a | n/a | n/a | n/a |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | n/a | 184K | n/a | 13.65M | n/a | 353K | n/a | 1.44M | 7.66M | 1.42M | 3.43M | -1.97M | 130K | 1.15M | -948K | 609K | 585K | 764K |
Financial Cash Flow | n/a | 1.18M | 1.74M | -110.87M | n/a | 18.76M | 6.43M | 1.44M | 58.18M | 5.66M | 4.6M | 98.03M | 130K | 26.85M | -780K | 609K | 585K | 764K |
Net Cash Flow | -13.47M | 28.06M | -37.24M | -4.41M | -38.51M | -16.78M | -41.95M | -59.61M | 134.68M | -68.19M | -42.37M | 78.57M | -26.37M | -26.63M | -39.46M | 153.46M | 7.42M | -49.47M |
Free Cash Flow | -13.47M | 26.88M | -38.97M | -34.81M | -39.91M | -35.3M | -48.38M | -61.05M | 64.75M | -80.65M | -56.35M | -60.83M | -52.06M | -69.39M | -53.44M | 123.65M | -42.25M | -30.84M |